Inflexion Pvt. Equity Partners LLP agreed to buy Pharmaspectra LLC, which provides medical affairs information to the pharmaceutical and biotechnological sectors.
The private equity firm is making the investment out of Inflexion Enterprise Fund IV, which focuses on the lower middle market.
Pharmaspectra will use the investment to expand its global presence in the key markets of the U.S., Europe and Asia, as well as expedite new product development.
